X

Health Care

AstraZeneca drops 6% after announcing $6.9 billion cancer drug deal with Daiichi Sankyo

Shares of AstraZeneca Plc (NYSE: AZN) dropped about 6% on NYSE during the pre-market hours and continued to trade in…

Biocept narrows loss in Q4

Biocept (BIOC) narrowed its loss in the fourth quarter, beating analyst estimates. However, sales failed to impress the street. Shares…

Advaxis shares plummet after reverse stock-split announcement

Nasdaq-listed late-stage biotech firm Advaxis, Inc. (NASDAQ:ADXS) focusses on discovery, development, and commercialization of immunotherapy products. The latest from this…

Why Amarin stock is rallying today

Amarin Corporation (NASDAQ: AMRN) shares got a major boost during the pre-market hours of Thursday after it said the American…

Arcadia Biosciences stock down despite solid Q4 results

Arcadia Biosciences (RKDA) stock decreased by nearly 2% in the extended hours of trading despite the fourth quarter results surpassed…

Earnings preview: What’s on the cards for Biocept in Q4

Biocept (BIOC) is scheduled to report fourth quarter and full year 2018 results on March 28, Thursday, after the regular…

Catalyst Pharmaceuticals stock soars to 12-year high

Catalyst Pharmaceuticals Inc. (CPRX) stock surged to a 12-year high of $5.59 on Wednesday. Investors were positive about the prospect…

Earnings: Affimed cuts down losses in 2018

Affimed N.V. (AFMD), a clinical stage biopharmaceutical company that focuses on oncology drugs, Wednesday reported net losses that narrowed in…

Fennec Pharma stock plunges to all-time low

Fennec Pharmaceuticals Inc. (FENC) stock plunged to an all-time low of $4.69 on Tuesday. Investors were concerned about the future…

Aldeyra Therapeutics stock resumes trading, surges about 60% on positive trial results

After getting halted in Nasdaq for sometime, shares of Aldeyra Therapeutics (ALDX) resumed trading and climbed up about 60% during…